Eli Lilly, Icos file for European approval

Lilly Icos, a joint venture between ICOS and LLY, filed with the EMEA for European marketing approval of Cialis oral PDE5 inhibitor to treat erectile dysfunction (ED). The partners filed an NDA with t...